Document is current
Any future updates will be listed below
-
Authors
Cole, Katherine Marie
Clemons, Mark
Alzahrani, Mashari
Liu, Michelle
Larocque, Gail
MacDonald, Fiona
Hutton, Brian
Piper, Ardelle
Fernandes, Ricardo
Pond, Gregory R.
Vandermeer, Lisa
Emam, Khaled El
McGee, Sharon F. https://orcid.org/0000-0002-0323-6372
- License Information
-
More Information
Article History
Received: 21 October 2021
Accepted: 18 January 2022
First Online: 2 February 2022
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the Ontario Cancer Research Ethics Board (OCREB).
: Informed consent was obtained from all individual participants included in the study, including consent to publish study findings.
: Mark Clemons reports honoraria from Pfizer, outside submitted work. Brian Hutton reports consulting fees from Cornerstone Research and Eversana, outside submitted work. Gregory Pond reports receipt of honorarium from Astra-Zeneca, Merck, Takeda, all outside the submitted work, and has a family member who is an employee of Roche and owns stock in Roche. Khaled El Emam holds equity in Replica Analytics Ltd., a software company spin-off from the University of Ottawa that develops synthetic data generation software. Sharon McGee reports honoraria from Novartis, outside the submitted work. All other authors declare no competing interests.
